178 related articles for article (PubMed ID: 21714428)
1. Mitral and aortic valvular disease associated with benfluorex use.
Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I
J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428
[TBL] [Abstract][Full Text] [Related]
2. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
[TBL] [Abstract][Full Text] [Related]
3. Valvular heart disease associated with benfluorex.
Gueffet JP; Piriou N; Trochu JN
Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
[No Abstract] [Full Text] [Related]
4. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
[TBL] [Abstract][Full Text] [Related]
5. [Valvular heart disease associated with benfluorex].
Rafel Ribera J; Casañas Muñoz R; Anguera Ferrando N; Batalla Sahún N; Castro Cels A; Pujadas Capmany R
Rev Esp Cardiol; 2003 Feb; 56(2):215-6. PubMed ID: 12605770
[TBL] [Abstract][Full Text] [Related]
6. Fenfluramine-like cardiovascular side-effects of benfluorex.
Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
[TBL] [Abstract][Full Text] [Related]
7. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209
[TBL] [Abstract][Full Text] [Related]
8. Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.
Le Ven F; Tribouilloy C; Habib G; Gueffet JP; Maréchaux S; Eicher JC; Blanchard-Lemoine B; Rousseau J; Hénon P; Jobic Y; Etienne Y
Eur J Echocardiogr; 2011 Apr; 12(4):265-71. PubMed ID: 21193484
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'.
Griffen L; Anchors M
Arch Intern Med; 1998 Jan; 158(1):102. PubMed ID: 9437392
[No Abstract] [Full Text] [Related]
10. Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
Baufreton C; Bruneval P; Rousselet MC; Ennezat PV; Fouquet O; Giraud R; Banfi C
Medicine (Baltimore); 2017 Jan; 96(2):e4985. PubMed ID: 28079786
[TBL] [Abstract][Full Text] [Related]
11. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
[TBL] [Abstract][Full Text] [Related]
12. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study.
Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D
Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218
[TBL] [Abstract][Full Text] [Related]
13. Valvular heart disease associated with fenfluramine-phentermine.
Connolly HM; Crary JL; McGoon MD; Hensrud DD; Edwards BS; Edwards WD; Schaff HV
N Engl J Med; 1997 Aug; 337(9):581-8. PubMed ID: 9271479
[TBL] [Abstract][Full Text] [Related]
14. Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy.
Ayme-Dietrich E; Lawson R; Gasser B; Dallemand R; Bischoff N; Monassier L
Fundam Clin Pharmacol; 2012 Apr; 26(2):215-8. PubMed ID: 22320434
[TBL] [Abstract][Full Text] [Related]
15. Calcifications in benfluorex-induced valve heart disease: a misknown association.
Plurien F; Bruneval P; Jobic Y; Iung B; Ennezat PV
Cardiology; 2015; 130(2):87-90. PubMed ID: 25614032
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of benfluorex on heart valves and pulmonary circulation.
Szymanski C; Andréjak M; Peltier M; Maréchaux S; Tribouilloy C
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):679-86. PubMed ID: 24817577
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension and benfluorex: 5 case reports.
Bondon-Guitton E; Prévôt G; Didier A; Montastruc JL
Therapie; 2011; 66(2):135-8. PubMed ID: 21635861
[TBL] [Abstract][Full Text] [Related]
18. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
Fournier A; Zureik M
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
[TBL] [Abstract][Full Text] [Related]
19. Histologic changes in three explanted native cardiac valves following use of fenfluramines.
Steffee CH; Singh HK; Chitwood WR
Cardiovasc Pathol; 1999; 8(5):245-53. PubMed ID: 10533956
[TBL] [Abstract][Full Text] [Related]
20. Operative finding of aortic cusp prolapse in benfluorex-induced aortic regurgitation.
Ennezat PV; Bruneval P; Maréchaux S; Bellemin JP; Senellart F; Arnaud-Crozat E; Ramadan R; Obadia JF; Touati G; Fleury JP; Tribouilloy C
Int J Cardiol; 2015; 186():231-2. PubMed ID: 25828122
[No Abstract] [Full Text] [Related]
[Next] [New Search]
